Advertisement
Home 2017 April

Monthly Archives: April 2017

Distinct bacterial taxa are seen in myalgic encephalomyelitis/chronic fatigue syndrome subgroups

Distinct Bacterial Taxa in ME/CSF Subgroups With/Without IBS

0
IBS co-morbidity is top driving factor in separation of topological networks based on bacterial profiles
Eleven novel adiposity variants have been identified after adjustment for physical activity (PA)

Exercise Reduces Weight Gain Effects in Those With FTO Gene

0
No evidence for interaction with physical activity for loci other than established FTO locus
Many older women have low awareness about osteoporosis and its contribution to fracture risk and a lack of understanding about the benefits of osteoporosis pharmacotherapy

Older Women Show Limited Understanding of Osteoporosis

0
Even after an osteoporosis-related fracture, few women are on pharmacotherapy
Medical marijuana laws are associated with a decline in the number of prescriptions filled for Medicaid enrollees

States With Medical Marijuana Laws See Drop in Prescriptions

0
Findings, based on Medicaid fee-for-service, are consistent with previous Medicare data
Physicians prescribing propranolol in a single concentration of 4.28 mg/mL for infantile hemangioma report fewer prescribing errors than those prescribing generic propranolol

Rx Errors Up With Generic Propranolol for Hemangioma

0
Dispensing, dose calculation errors more common with generic propranolol for infantile hemangioma
Medication adherence is better for combination prescription initiators with fibromyalgia syndrome

Combo Rx for Fibromyalgia Tied to Higher Adherence

0
However, combination prescription initiation also tied to higher health care costs
A proposal to replace private insurance with government-funded health care for all moved forward in California on Wednesday as Democrats on the Senate Health Committee voted to advance the measure.

Single-Payer Health System Bill Moves Forward in California

0
Not yet clear where money for the single-payer system would come from
U.S. Food and Drug Administration approval of the kinase inhibitor regorafenib has been expanded to include hepatocellular carcinoma

Regorafenib Approved for Hepatocellular Carcinoma

0
It is the first approved treatment for HCC in almost a decade
Three anti-vascular endothelial growth factor treatments are associated with low rates of diabetic retinopathy worsening

Three Anti-VEGF Treatments Effective for Diabetic Retinopathy

0
Rates of worsening low in patients receiving aflibercept, bevacizumab, or ranibizumab
Approximately one-fourth of eyes deemed to be normal based on eye examination by primary eye care physicians have age-related macular degeneration determined by fundus photography and trained raters

Undiagnosed Macular Degeneration Appears Common

0
Nearly one-fourth of eyes deemed normal in primary care eye exam found to have AMD